
|Articles|October 1, 2004
Cancer vaccine prompts robust immune response
The vaccine combines NY-ESO-1 with IMX, a potent immune-system stimulator that consists of cholesterol, phospholipids and saponin.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
4
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
5











